Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 12, 2019
Patent Application Number
16007151
Date Filed
June 13, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
